U.S. CMS Caps GLP-1 Drug Cost at $50 Monthly for Medicare Beneficiaries Starting July 1

According to the Centers for Medicare & Medicaid Services (CMS), eligible Medicare beneficiaries will pay a maximum of $50 per month for GLP-1 drugs starting July 1, 2026. The policy aims to improve access to these weight-loss and diabetes medications for seniors.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments